Critical Care Research Group, Faculty of Medicine, University of Queensland and The Prince Charles Hospital, Brisbane, Australia.
Department of Pediatrics, Chonnam National University Children's Hospital and Medical School, Gwangju, Republic of Korea.
Crit Care. 2020 Jun 6;24(1):301. doi: 10.1186/s13054-020-02979-3.
The spread of coronavirus disease 2019 (COVID-19) continues to grow exponentially in most countries, posing an unprecedented burden on the healthcare sector and the world economy. Previous respiratory virus outbreaks, such as severe acute respiratory syndrome (SARS), pandemic H1N1 and Middle East respiratory syndrome (MERS), have provided significant insights into preparation and provision of intensive care support including extracorporeal membrane oxygenation (ECMO). Many patients have already been supported with ECMO during the current COVID-19 pandemic, and it is likely that many more may receive ECMO support, although, at this point, the role of ECMO in COVID-19-related cardiopulmonary failure is unclear. Here, we review the experience with the use of ECMO in the past respiratory virus outbreaks and discuss potential role for ECMO in COVID-19.
2019 年冠状病毒病（COVID-19）在大多数国家继续呈指数级传播，给医疗保健部门和世界经济带来了前所未有的负担。以前的呼吸道病毒爆发，如严重急性呼吸综合征（SARS）、大流行性 H1N1 和中东呼吸综合征（MERS），为包括体外膜氧合（ECMO）在内的重症监护支持的准备和提供提供了重要的见解。在当前的 COVID-19 大流行中，许多患者已经接受了 ECMO 的支持，而且可能有更多的患者需要接受 ECMO 支持，尽管目前 ECMO 在 COVID-19 相关心肺衰竭中的作用尚不清楚。在这里，我们回顾了过去呼吸道病毒爆发中使用 ECMO 的经验，并讨论了 ECMO 在 COVID-19 中的潜在作用。
